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Neisseria gonorrhoeae is capable of iron utilization from human transferrin in a receptor-mediated event.
Transferrin-binding protein 1 (Tbp1) and Tbp2 have been implicated in transferrin receptor function, but their
specific roles in transferrin binding and transferrin iron utilization have not yet been defined. We utilized
specific gonococcal mutants lacking Tbp1 or Tbp2 to assess the relative transferrin-binding properties of each
protein independently of the other. The apparent affinities of the wild-type transferrin receptor and of Tbp1
and Tbp2 individually were much higher than previously estimated for the gonococcal receptor and similar to
the estimates for the mammalian transferrin receptor. The binding parameters of both of the mutants were
distinct from those of the parent, which expressed two transferrin-binding sites. Tbp2 discriminated between
ferrated transferrin and apotransferrin, while Tbp1 did not. Results of transferrin-binding, affinity purifica-
tion, and protease accessibility experiments were consistent with the hypothesis that Tbp1 and Tbp2 interact
in the wild-type strain, although both proteins were capable of binding to transferrin independently when
separated in the mutants. The presence of Tbp1 partially protected Tbp2 from trypsin proteolysis, and Tbp2
also protected Tbp1 from trypsin exposure. Addition of transferrin to wild-type but not mutant cells protected
Tbp1 from trypsin but increased the trypsin susceptibility of Tbp2. These observations indicate that Tbp1 and
Tbp2 function together in the wild-type strain to evoke binding conformations that are distinct from those
expressed by the mutants lacking either protein.
With few exceptions, microorganisms require inorganic iron
as a cofactor for various metabolic processes, including RNA
synthesis, electron transport, and oxygen detoxification (11).
The vast majority of iron available in a mammalian host is
found intracellularly in the forms of heme, hemosiderin, or
ferritin or complexed with metalloproteins (56). Extracellular
iron stores include transferrin, lactoferrin, and hemoglobin,
the last of which results from erythrocyte lysis and is ordinarily
complexed with the serum protein haptoglobin. Sequestration
of iron by these iron-binding proteins and compounds effec-
tively lowers the concentration of available soluble ferric iron
to a level insufficient to allow bacterial growth. To circumvent
this phenomenon, which has been termed nutritional immunity
(56), pathogenic microorganisms have evolved at least four
mechanisms to acquire iron from these compounds. Reduction
of ferric iron to ferrous iron by secreted reductases, resulting in
release of iron from the iron-binding compound, is a strategy
employed by some bacteria, including Listeria monocytogenes
(17, 18). Pseudomonas aeruginosa secretes proteases that, in
conjunction with neutrophil-derived products, are capable of
modifying transferrin and lactoferrin such that they unload
their iron (12). Many microbes synthesize or utilize exog-
enously made siderophores, low-molecular-mass compounds
that can scavenge the iron from host iron-containing com-
pounds. The synthesis of siderophores and their high-affinity
acquisition systems located in the cell envelope are regulated
by the availability of iron in the environment (6, 37). Several
bacterial pathogens make no identifiable siderophores but in-
stead have evolved systems whereby they can scavenge the iron
directly from host iron-binding compounds by a high-affinity,
receptor-mediated mechanism. Of these pathogens, Neisseria
spp., Haemophilus spp., and Actinobacillus pleuropneumoniae
have some of the best-characterized, iron uptake systems (2, 5,
15, 20–23, 30, 34–36, 38, 47, 48, 57).
The pathogenic Neisseria spp. can obtain iron directly from
the glycoproteins transferrin and lactoferrin as well as from
heme and hemoglobin (33). The mechanism of iron acquisition
from transferrin has been the most thoroughly studied (for a
review, see reference 16). Binding of transferrin for the patho-
genic Neisseria spp. is saturable and species specific in that the
neisserial receptor is capable of recognizing only human trans-
ferrin (9, 28, 48, 54). Transferrin is not internalized but is
deferrated at the cell surface by an unknown mechanism, and
the iron enters the cell in an energy-dependent fashion (4, 32,
50). Affinity purification was utilized to identify two proteins,
transferrin-binding protein 1 (Tbp1) and Tbp2, which have
subsequently been shown, biochemically and genetically, to be
involved in transferrin receptor function (2, 9, 15, 23, 30).
Mutants lacking Tbp1 exhibit diminished transferrin binding,
cannot internalize transferrin-bound iron, and are incapable of
growth on transferrin as the sole iron source (15, 23). The
predicted protein sequence of Tbp1 suggests that it is a mem-
ber of the family of TonB-dependent outer membrane recep-
tors (15, 30), some of which are required for entry of iron
complexes in enteric bacteria (10, 26). Tbp2 is acetylated and
is not a member of the TonB-dependent family (2). Gonococ-
cal Tbp22 mutants are capable of growth on transferrin-de-
rived iron, but the efficiency of iron uptake from transferrin is
decreased compared with that of wild-type levels (2). In con-
trast, both meningococcal Tbp22 and Tbp12 mutants are in-
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capable of growth on transferrin-bound iron (23), although in
other respects the gonococcal and meningococcal transferrin
iron uptake systems are very similar.
These observations have been incorporated into a model of
iron acquisition from transferrin by these organisms (for a
review, see reference 16) based primarily on the analogy with
TonB-dependent uptake of siderophores and vitamin B12. In
this model, Tbp1 forms an energy-dependent, gated, pore (25,
31, 44) or pump (41) through which the transferrin-derived
iron crosses the outer membrane, while Tbp2 is suggested to
increase the efficiency of the receptor. Other aspects of a
transferrin iron utilization system include Fbp, which is sug-
gested to be the periplasmic binding protein component of
high-affinity iron uptake from transferrin and citrate (13); the
tlu gene product, which is required for iron utilization from
transferrin and lactoferrin (9); TonB, which has not yet been
identified in the pathogenic Neisseria spp. but has been sug-
gested to exist in all gram-negative bacteria to energize outer
membrane receptors (40); a cytoplasmic membrane permease
(1) to allow the ferric iron to cross the cytoplasmic membrane;
and a reductase (29) to convert ferric iron, the form bound to
Fbp, to ferrous iron, the form found in the cytoplasm.
The purpose of this study was to define more precisely the
roles that Tbp1 and Tbp2 play in transferrin binding. We have
used a combination of liquid-phase and solid-phase (dot blot)
transferrin-binding assays to determine the relative contribu-
tions that Tbp1 and Tbp2 make to the affinity and specificity of
the receptor. Additionally, we present data from affinity puri-
fication and protease accessibility experiments suggesting that
the presence of Tbp1 affects the conformation or exposure of
Tbp2 while the presence of Tbp2 alters the protease exposure
of Tbp1.
MATERIALS AND METHODS
Strains and growth conditions. The gonococcal strains used in this study were
previously described (2, 15, 34). Gonococci were routinely maintained on Bacto
GC medium base (Difco) plates containing Kellogg’s supplement I (24) and 12
mM Fe(NO3)3 in a 5% CO2 atmosphere at 358C. To induce iron-stressed growth,
bacteria were grown in CDM-0 (58) which was rendered iron-free by treatment
with Chelex-100 (Bio-Rad, Richmond, Calif.). During the course of this study, we
determined that the gonococcal strain FA6819 expressed a stable, truncated
version of Tbp2 to which transferrin did not bind (data not shown). We con-
structed another mutant in which the 39 2,058 bases of the 2,127-base Tbp2 open
reading frame were deleted. This mutant did not make a stable Tbp2 peptide and
was identical to FA6819 in iron uptake experiments, transferrin-binding exper-
iments, and protease protection experiments (data not shown).
Preparation and labeling of human transferrin. Human transferrin (Calbio-
chem, San Diego, Calif.) was ferrated as previously described (9). Ferrated
transferrin (94% saturated as measured by a ferrozine assay [51]) was iodinated
using Iodogen (Pierce, Rockford, Ill.) according to the manufacturer’s recom-
mendations. 125I label was separated from the iodinated transferrin by passage
over a desalting column (Econo-Pac; Bio-Rad).
Liquid-phase, transferrin-binding assay. Nonpiliated, transparent gonococci
were grown overnight on Bacto GC medium base plates and then inoculated into
liquid CDM-0. After one mass doubling, cells were diluted 1:4 in fresh CDM-0
and grown 3 h. In experiments to measure transferrin binding to sialylated
gonococci, cytidine 59-monophospho-N-acetylneuraminic acid (CMP-NANA;
Sigma, St. Louis, Mo.) was added to a final concentration of 5 mg/ml with the
addition of fresh CDM-0, and then cultures were grown 3 h to induce iron stress
and sialylation. Approximately 1 3 107 to 5 3 107 CFU in growth medium was
mixed with various amounts of 125I-transferrin in the presence of 10 mg of bovine
serum albumin per ml in individual wells of a Multi-Screen microtiter dish
(0.45-mm-pore-size filter; MAHV N45; Millipore, Cambridge, Mass.). Trans-
ferrin was allowed to bind to cells for 20 min at room temperature, and unbound
transferrin was removed by filtration followed by three washes with CDM-0.
Filters at the bottom of the Multi-Screen microtiter dishes were punched out and
counted with a gamma scintillation counter. In order to standardize binding
assays to total cellular protein, wells containing cells only were similarly pro-
cessed, except that they were washed with phosphate-buffered saline, and as-
sayed for protein content by the bicinchoninic acid (BCA) assay (Pierce). Total
transferrin bound was then normalized to micrograms of total cellular protein.
Three identical experiments, including growth and iron stress experiments, were
conducted. Each datum point represents the mean of the three independent
experiments. In individual binding assays, each concentration was tested in du-
plicate. Nonspecific binding was also measured at each concentration by addition
of excess cold, 94% saturated transferrin (3.8 mM). Specific binding was calcu-
lated by subtracting nonspecific binding from total counts for each transferrin
concentration. The specific activity of iodinated transferrin was 5.0 3 105 to 5.5
3 105 cpm/mg. Copy number and Kd estimates were obtained by using Lundon-1
(Lundon Software, Inc.; Cleveland, Ohio), which applies a nonlinear, curve-
fitting algorithm to binding data.
A competitive, liquid-phase, transferrin-binding assay was conducted essen-
tially as described above except that the unlabeled competitor concentration
varied from 0 to 1.5 mM and the iodinated transferrin concentration was held
constant at 100 nM. Each dilution of competitor contained ferrated (94% satu-
rated) transferrin or apotransferrin in addition to 0.8 mM deferoxamine mesylate
(Desferal; CIBA Pharmaceuticals).
Competitive solid-phase, transferrin-binding assay. Approximately 1 3 107 to
5 3 107 CFU of iron-stressed gonococci was applied to nitrocellulose filters and
allowed to dry. Filters were then probed with a mixture of unlabeled competitor
transferrin (95% saturated transferrin or apotransferrin; Sigma) and horseradish
peroxidase (HRP)-labeled transferrin (Jackson ImmunoResearch; West Grove,
Pa.) essentially as described previously (14). The commercially available HRP-
labeled human transferrin was partially saturated with iron and prepared by
conjugation of activated peroxidase to amino groups on human transferrin. Serial
1:2 dilutions were made in the presence of 0.8 mM deferoxamine mesylate.
Batch affinity purification of transferrin-binding proteins from gonococcal
mutants. Membrane proteins and biotinlyated transferrin were prepared as
described previously (15). Batch affinity purification was performed essentially as
indicated previously (15) except that 5 mg of total membrane protein was used
as starting material. Either 0.5% Sarkosyl (n-lauroylsarcosine) or 0.1% Triton
X-100 (Pierce) was used to solubilize membrane proteins in the presence of 1
mMEDTA. Specificities of the binding reactions were determined by performing
mock-affinity assays in the absence of biotinlyated transferrin. Wash conditions
included 100 mM, 500 mM, or 1 M NaCl for purification of transferrin-binding
proteins from FA19 with Sarkosyl, as indicated in the legend to Fig. 6. Wash
solutions for proteins isolated with Triton X-100 from FA19 contained 1 M
NaCl, from FA6747 contained 500 mM NaCl, and from FA6819 contained 1 M
NaCl.
Protease accessibility of Tbp1 and Tbp2. Iron-stressed gonococci were grown
as described above for the transferrin-binding assays and then treated with
trypsin (Sigma) at a concentration of 2.5 mg/ml for 0 to 30 min. Protease
treatment was stopped by addition of 0.6 trypsin-inhibiting units of aprotinin
(Sigma), and this was followed by centrifugation, resuspension of the bacterial
pellet in loading buffer (27), and boiling for 2 min. Protease-treated whole-cell
lysates were separated on 7.5% polyacrylamide gels (27), and proteins were
blotted to nitrocellulose filters (53) for 16 h at 40 mA. Western blots (immuno-
blots) were probed with anti-Tbp1 antiserum (15) or with HRP-labeled trans-
ferrin to detect Tbp2 (2, 15). Blots probed with HRP-labeled transferrin were
visualized with ECL reagents (Amersham, Arlington Heights, Ill.) and exposed
to Kodak X-Omat film. For protease accessibility experiments in the presence of
transferrin, transferrin was added to a final concentration of 100 nM before cells
were treated with trypsin. Protease-treated cells were subsequently processed as
indicated above.
RESULTS
Transferrin binding to gonococcal mutants. We compared
the transferrin-binding characteristics of a panel of gonococcal
strains including FA19 (Tbp11 Tbp21), FA6747 (Tbp12 Tbp21),
FA6819 (Tbp11 Tbp22), and FA6815 (Tbp12 Tbp22). The tbpB
and tbpA loci of these mutants, which encode Tbp2 and Tbp1,
respectively, are shown in Fig. 1. A polar transposon insertion
mutation in tbpB generated FA6815, which did not express
Tbp1 or Tbp2 (2) and did not bind transferrin in solid-phase
dot blot (data not shown) or in liquid-phase (data not shown)
transferrin-binding assays. As shown in Fig. 2, the strain that
expressed only Tbp1 bound significantly less transferrin that
did the wild-type strain or the strain that expressed only Tbp2.
Binding data from these experiments were analyzed with the
program Lundon-1, which uses a nonlinear, curve-fitting algo-
rithm to estimate copy numbers and Kd. The predictions made
by the nonlinear models best fit the binding data from all
strains. Binding data from FA19, when plotted according to the
Scatchard-Rosenthal method (7, 43, 45), yielded a curve, as
shown in Fig. 3A. The dotted lines in Fig. 3A represent the two
binding components estimated by Lundon-1 that best fit the
binding data. The apparent Kd estimates in the two-site model
shown in Fig. 3A were Kd1 5 0.8 nM and Kd2 5 16 nM. The
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copy number estimates of the two binding components were
approximately 1.2 3 109 and 7.2 3 109 molecules per mg of
total cellular protein for the first and second components,
respectively. This analysis assumes that these represent two
separate, noninteracting binding sites. However, without ki-
netic data we cannot differentiate between the presence of two
discrete sites and the presence of multiple sites that interact
noncooperatively. Binding data from FA6747 (Tbp12 Tbp21)
and FA6819 (Tbp11 Tbp22) were consistent with the model of
a single transferrin-binding component in each of these strains.
The Scatchard-Rosenthal plots of binding data from trans-
ferrin binding to FA6747 (Tbp12 Tbp21) and FA6819 (Tbp11
Tbp22) are shown in Fig. 3B and C, respectively. Lundon-1
analysis indicated that Tbp2 (Fig. 3B) expressed in the absence
FIG. 1. The tbpB and tbpA loci of gonococcal mutants. The tbpB gene en-
codes Tbp2; the tbpA gene encodes Tbp1. P indicates the approximate location
of a putative promoter upstream of the tbpB and tbpA genes. The arrows indicate
the direction of translation of the genes. The inverted triangles indicate the
approximate positions of transposon insertions in tbpA and tbpB. The jagged
ends of the box representing tbpB in FA6819 indicate that most of the structural
gene has been deleted. The tbpA gene is flanked by inverted repeats represented
by hairpin symbols.
FIG. 2. Isotherm of transferrin binding to mutants. The plot shows the
amount of specifically bound transferrin as a function of transferrin concentra-
tion. Open squares indicate binding to FA19 (wild type), closed triangles indicate
binding to FA6747 (Tbp12 Tbp21), and closed squares indicate binding to
FA6819 (Tbp11 Tbp22). Datum points represent means of three individual
experiments. Error bars indicate standard deviations within each triplicate set.
FIG. 3. Scatchard-Rosenthal plots of binding data. Analyses of binding data
from FA19 (wild-type) (A), FA6747 (Tbp12 Tbp21) (B), and FA6819 (Tbp11
Tbp22) are shown. The dotted lines in panel A represent the binding sites
predicted by a two-site model (Lundon-1). These two binding sites correspond to
the Kd and copy number estimates: Kd1, 0.8 nM; Kd2, 16 nM; N1, 1.2 3 109
molecules per mg; N2, 7.2 3 109 molecules per mg. Kds and copy numbers
predicted by the single-site model (Lundon-1) for FA6747 (Tbp12 Tbp21) (B)
were 7.4 nM and 9.4 3 109 molecules per mg, respectively, and those for FA6819
(Tbp11 Tbp22) (C) were 2.3 nM and 1.8 3 109 molecules per mg, respectively.
The lines in panels B and C do not intersect all of the points since they represent
the best-fit, single-site binding parameters estimated by the nonlinear algorithm
of Lundon-1 and do not represent the least-squares, linear relationship between
the points. B/F, bound/free ratio.
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of Tbp1 bound transferrin with an apparent Kd of 7.4 nM, and
the Tbp2 copy number was approximately 9.5 3 109 molecules
per mg of total cellular protein in this strain. Analysis of bind-
ing data from FA6819 (Fig. 3C) indicated that Tbp1, expressed
in the absence of Tbp2, bound transferrin with a Kd of 2.3 nM
and a copy number of approximately 1.8 3 109 molecules per
mg of total cellular protein. The lines in Fig. 3B and C do not
intersect all of the points since they represent the best-fit,
single-site binding parameters estimated by the nonlinear al-
gorithm of Lundon-1 and do not represent the least-squares,
linear relationship between the points.
Competitive transferrin binding in solid phase. The gono-
coccal transferrin receptor as expressed in FA19 was previ-
ously shown to discriminate slightly (4- to 16-fold) between
apo- and ferrated forms of transferrin in a solid-phase, trans-
ferrin-binding assay (9). We assessed the ability of the Tbp12
and Tbp22 mutants to discriminate between the different
forms of transferrin in the same assay format. Deferoxamine
mesylate was also added during the assay whose results are
depicted in Fig. 4 so that the competitor apotransferrin could
not scavenge contaminating iron during the course of the ex-
periment. As shown in Fig. 4, both the wild-type strain and
FA6747 (Tbp12 Tbp21) were capable of discriminating be-
tween apo- and ferrated forms of transferrin, as evidenced by
the inability of excess apotransferrin to block binding of fer-
rated, HRP-labeled transferrin. FA6819 (Tbp11 Tbp22), how-
ever, did not appear to discriminate between ferrated trans-
ferrin and apotransferrin, since both forms competed equally
well with the ferrated, HRP-labeled transferrin for binding.
These results indicated that Tbp2 was capable of discerning
between apo- and ferrated forms of transferrin and suggested
that Tbp2, rather than Tbp1, might be responsible for the
discriminatory phenotype of the receptor in FA19. We also
noted that FA6747 (Tbp12 Tbp21) in this assay format bound
much less transferrin relative to the wild-type strain than it did
in the liquid-phase format (compare FA6747 and FA19 curves
in Fig. 2). Tbp2 expressed in the absence of Tbp1 may be more
susceptible to the drying process used in the solid-phase format
or the washing procedures of the two formats may differ suf-
ficiently such that transferrin binding to Tbp2 in solid-phase
experiments was underestimated.
Competitive transferrin binding in liquid phase. The ability
of Tbp1 and Tbp2 to discriminate between ferrated transferrin
and apotransferrin was also assessed in a liquid-phase binding
assay format. As shown in Fig. 5A, FA19 showed a modest but
statistically significant ability to discriminate between ferrated
transferrin and apotransferrin at the two highest concentra-
tions of competitor tested (P value of 0.02 at 500 nM trans-
ferrin; P value of 9.5 3 1025 at 1,500 nM transferrin). In
contrast, FA6747 (Tbp12 Tbp21) showed a striking preference
for ferrated transferrin in that apotransferrin was hardly rec-
ognized at all by this strain (Fig. 5B). FA6819 (Tbp11 Tbp22)
did not distinguish between the ferrated and apo-forms of
transferrin (Fig. 5C).
Effect of sialylation on liquid-phase transferrin binding.
Since sialylation of gonococcal lipooligosaccharide has been
shown to hinder access of antibody to outer membrane porins
(19), we wanted to determine if this modification affected the
accessibility of the transferrin receptor. We tested the effect of
growth with CMP-NANA on liquid-phase transferrin binding
to the panel of gonococcal strains. Sialylation of the lipooligo-
saccharide of FA19 did not change the ability of the transferrin
receptor to bind its ligand (data not shown). Sialylated strains
FA6747 (Tbp12 Tbp21) and FA6819 (Tbp11 Tbp22) were
similarly unaffected in transferrin binding (data not shown).
Strains from each of the three assays were effectively sialylated
under the growth conditions used since cultures grown in the
presence of CMP-NANA lost the ability to bind the 3F11 (3)
monoclonal antibody (data not shown).
Affinity purification of Tbps from gonococcal mutants. Irwin
et al. (23) demonstrated that meningococcal Tbp2 could not be
affinity purified from a mutant lacking Tbp1 and concluded
from this that Tbp1 and Tbp2 interact with each other in the
wild-type strain. The results presented in Fig. 6 indicated that,
like its meningococcal homolog, gonococcal Tbp2 could not be
purified from FA6747 (Tbp12 Tbp21) in the presence of Sar-
kosyl (Fig. 6B, lanes 7 and 8). However, Tbp2 could be affinity
purified from FA6747 (Tbp12 Tbp21) in the presence of the
nonionic detergent Triton X-100 (Fig. 6B, lane 9). This binding
was specific and not due to incomplete solubilization, since no
Tbp2 was purified in the mock experiment to which no bio-
tinylated transferrin was added (Fig. 6B, lane 10). The absence
of Tbp2 did not affect the ability to purify Tbp1 from FA6819
(Tbp11 Tbp22) (Fig. 6A, lanes 11 to 14). Increasing the salt
concentration in the wash solutions modestly increased the
yield of Tbp1 and Tbp2 from FA19 (Fig. 6A, lanes 1, 2, and 3).
Protease accessibility of Tbp1 and Tbp2 in gonococcal mu-
tants. We assessed surface exposure of the individual trans-
ferrin-binding proteins by exposing the iron-stressed wild-type
and mutant strains to trypsin. The results presented in Fig. 7
showed that both Tbp1 and Tbp2 were accessible in the wild-
type strain to low concentrations of trypsin, indicating that
both proteins were surface exposed. Data shown in Fig. 7A
indicated that Tbp1 was more susceptible to proteolytic attack
in the absence of Tbp2 (Fig. 7A, compare lanes 3 to 5 and lanes
13 to 15). Virtually all of the Tbp2 expressed in the absence of
Tbp1 was readily accessible to trypsin, and transferrin-binding
FIG. 4. Solid-phase, transferrin-binding assay. Rows of dots contain iron-
stressed whole cells of FA19 (wild type), FA6747 (Tbp12 Tbp21), and FA6819
(Tbp11 Tbp22), as indicated at right. Probes for rows: None, 0.33 mg of HRP-
labeled transferrin (2.8 nM) per ml without any competitor added; Ferrated, 0.33
mg of HRP-labeled transferrin (2.8 nM) per ml mixed with twofold dilutions of
saturated transferrin as competitor; Apo, 0.33 mg of HRP-labeled transferrin per
ml mixed with twofold dilutions of apotransferrin as competitor. Competitor
concentrations for columns (micromolar): 1, 6.4; 2, 3.2; 3, 1.6; 4, 0.8; 5, 0.4; 6, 0.2;
7, 0.1; 8, 0.05. All HRP-labeled transferrin solutions included 0.8 mM deferox-
amine mesylate. The blot was scanned with a Relisys 2412 scanner, and the image
was annotated with Adobe Photoshop software.
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activity was completely abolished by 10 min. For the wild-type
strain, a fraction of the Tbp2 expressed was accessible to tryp-
sin but a population remained resistant to cleavage for at least
30 min (Fig. 7B). This resistant population was recalcitrant to
degradation even when trypsin concentrations were increased
10-fold (data not shown). Since Fbp, a basic, periplasmic pro-
tein (8) was not affected by trypsin exposure in these experi-
ments (data not shown), we conclude that gross lysis, which
could expose proteins that otherwise were not surface exposed,
was not occurring.
Protease accessibility of Tbp1 and Tbp2 in the presence of
transferrin.We added saturating concentrations of transferrin
before exposing the cells to trypsin to determine whether li-
gand binding effected exposure of trypsin recognition sites.
Under the experimental conditions used here, transferrin was
not detectably digested by trypsin (data not shown). Tbp1 was
protected from trypsin in the presence of transferrin (compare
Fig. 7A and 8A), most profoundly so in the wild-type strain
that also expressed Tbp2 (lanes 1 to 5 of Fig. 7A and 8A). After
10 min of trypsin exposure, full-length Tbp1 was noticeably
diminished in the absence of Tbp2 (compare lanes 12 and 13).
The protease digest pattern of Tbp2 was not dramatically al-
tered in the presence of transferrin, although comparison of
Fig. 7B and 8B indicates that Tbp2 might be more protected
from trypsin in the absence of transferrin. Tbp2 detection in
these experiments required binding of peroxidase-conjugated
transferrin; thus, the 58-kDa trypsin-digest product seen in
lanes 5 and 6 of Fig. 8B remained capable of binding transferrin.
DISCUSSION
Although we know that both Tbp1 and Tbp2 bind transferrin
and somehow contribute to the ability of the gonococci to
utilize transferrin as an iron source (2, 15), we do not know the
precise roles that each of these proteins play in transferrin
binding and growth on transferrin-derived iron. This study
using specific gonococcal mutants lacking either Tbp1 or Tbp2
was designed to begin to answer these questions. The results
presented here indicate that Tbp1 and Tbp2 expressed inde-
pendently in the mutants bound transferrin with relatively high
affinity in the liquid-phase binding experiments. The apparent
affinities of each binding protein and of the wild-type receptor
FIG. 5. Competitive liquid-phase transferrin binding to mutants. Percentages
of transferrin specifically bound to FA19 (wild type) (A), FA6747 (Tbp12
Tbp21) (B), and FA6819 (Tbp11 Tbp22) (C) as functions of competitor con-
centration are shown. Open squares represent binding in the presence of apo-
transferrin, and closed circles represent binding in the presence of ferrated
transferrin. Datum points represent means of three individual experiments. Er-
ror bars indicate standard deviations within each triplicate set.
FIG. 6. Affinity-purified, transferrin-binding proteins. Western blots probed
with anti-Tbp1 antiserum (A) and with HRP-labeled transferrin to visualize
Tbp2 (B). Lanes 1 to 6, affinity-purified proteins purified from FA19 (wild type);
lanes 7 to 10, FA6747 (Tbp12 Tbp21); lanes 11 to 14, FA6819 (Tbp11 Tbp22).
S and T, proteins isolated in the presence of Sarkosyl and Triton X-100, respec-
tively. Lanes 1, 2, and 3 contain proteins purified from FA19 in Sarkosyl in the
presence of 100 mM, 500 mM, and 1 M NaCl, respectively. Even-numbered lanes
from 4 to 14 contain proteins isolated in control experiments to which no
transferrin was added. Approximate positions of molecular mass standards are
indicated at right. Blots were scanned with a Relisys 2412 scanner, and images
were annotated with Adobe Photoshop software.
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were considerably higher than that reported previously for the
transferrin receptor in the same gonococcal strain, FA19 (9).
Previous estimates and those presented here for the gonococ-
cal transferrin receptor may differ for several technical reasons.
Blanton et al. (9) indicated that their calculated affinity may
have been underestimated because of the slow centrifugation
procedure used to separate bound from unbound ligand. The
data presented in this work were generated by using a rapid
filtration step that allowed unbound ligand to be separated
from cells and bound ligand in approximately 15 s. In equilib-
rium-phase binding studies of receptors with affinities in the
nanomolar range, the allowable separation time is approxi-
mately 1.7 min (7), which is considerably less time than was
required to complete the centrifugation-based washes used in
the previous study. Additionally, Kd is influenced by the recep-
tor number, with apparent Kd increasing with receptor concen-
tration (7). Thus, binding assays ideally should be conducted
with the lowest possible receptor number; the binding studies
presented here were conducted with 20- to 100-fold fewer cells
per assay than those of previous studies. A filtration-based
separation might also retain blebs and membrane fragments
that could otherwise be lost by centrifugation, increasing the
yield of total bound counts.
One interpretation of the observation of two transferrin-
binding sites in the wild-type gonococcus is that these two
binding sites represented the two characterized binding pro-
teins. The copy numbers of the individual binding components
in the wild-type strain suggested that the low-affinity site was
sixfold more prevalent in cultures grown under these condi-
tions. The estimates of Kd indicated that the wild-type binding
sites differed in affinity by about 20-fold. This interpretation,
however, is based upon the assumption that the binding pro-
teins are noninteracting; that is, binding of transferrin to the
first protein had no effect, sterically or conformationally, on
binding to the second protein. We do not know this to be true,
and in fact, other evidence indicated that the proteins did
interact with one another (see below). Thus the two binding
sites in the wild-type strain might be interpreted as two con-
formational states of a complex receptor, composed of both
Tbp1 and Tbp2. Note that since the binding assays were con-
ducted in growth media containing glucose and at room tem-
perature, the cells were energized and capable of iron uptake
from transferrin, a process which changes the ligand. Thus,
both the ligand and the conformation of the receptor were
potentially changing during the course of the assay. Analysis of
the mutants indicated that neither protein expressed individu-
ally bound transferrin with binding parameters that approxi-
mated those of the wild-type strain. This suggested that the
wild-type binding phenomena resulted from the combination
of Tbp1 and Tbp2 at the cell surface. Determination of the
precise stoichiometry of Tbp1 and Tbp2 in the wild-type strain
will require further experimentation. Extrapolation from bind-
ing data obtained with the mutants to wild-type stoichiometry
estimates could lead to erroneous conclusions. However, the
mutant data indicated that the transferrin-binding site com-
posed of Tbp1 only was about threefold higher in affinity than
that composed of Tbp2 only. There were also ca. fivefold more
Tbp2-specific transferrin-binding sites than Tbp1-specific bind-
ing sites as indicated by analysis of the mutants expressing
either of these proteins individually.
Copy number estimates are reported here as numbers of
sites per microgram of total cellular protein rather than the
more traditional numbers of sites per CFU. All receptors in the
culture remained competent to bind transferrin, even if they
resided on cell fragments rather than viable cells. Conversion
to CFU from micrograms of whole-cell protein is further com-
plicated by the observation that the Tbp12 mutant was the
least viable of the tested strains; that is, there were fewer CFU
per microgram of whole-cell protein in cultures of this strain
(data not shown). However, we could estimate that in the
FIG. 7. Protease accessibility of transferrin-binding proteins. Western blots
probed with anti-Tbp1 antiserum (A) and HRP-labeled transferrin to visualize
Tbp2 (B). Lanes 2 to 5, trypsin-treated, whole-cell lysates of FA19 (wild type);
lanes 7 to 10, FA6747 (Tbp12 Tbp21); lanes 12 to 15, FA6819 (Tbp11 Tbp22).
Lanes 1, 6, and 11 contain untreated whole-cell lysates from FA19, FA6747, and
FA6819, respectively. Whole cells were treated with trypsin for 0 min (lanes 2, 7,
and 12), 10 min (lanes 3, 8, and 13), 20 min (lanes 4, 9, and 14), and 30 min (lanes
5, 10, and 15). Approximate positions of molecular mass standards are indicated
at right. Blots were scanned with a Relisys 2412 scanner, and images were
annotated with Adobe Photoshop software.
FIG. 8. Protease accessibility of Tbp1 and Tbp2 in the presence of trans-
ferrin. Panels and lanes are as described in the legend to Fig. 7. Cultures were
mixed with 100 nM transferrin prior to trypsin exposure. Approximate positions
of molecular mass standards are indicated at right. Blots were scanned with a
Relisys 2412 scanner, and images were annotated with Adobe Photoshop soft-
ware.
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wild-type strain grown under these conditions, there were ap-
proximately 750 high-affinity and 4,700 low-affinity binding
sites per CFU.
Overall, the affinities of the transferrin receptor in the wild-
type strain and of Tbp1 and Tbp2 individually are near the
estimates made for the mammalian receptor, Kd, i.e., 5 to 20
nM (55). Thus, the bacterial receptor could effectively compete
with its mammalian counterpart in vivo, even at low transferrin
concentrations such as those probably existing on mucosal sur-
faces (42), and in other nonhematogenous gonococcal niches
(39, 49). In fact, this analysis indicated that the high-affinity
binding site on the wild-type gonococcus was capable of bind-
ing transferrin with even higher affinity than its mammalian
counterpart. Binding transferrin with such a high affinity might
necessitate a mechanism by which the receptor could recognize
the deferrated ligand and, in a distinct step, release it from the
receptor.
The mutant that expressed only Tbp2 showed a striking
ability to discriminate between ferrated transferrin and apo-
transferrin. Tbp2 had a 100-fold higher affinity for ferrated
transferrin than for apotransferrin, which is similar to the fig-
ure quoted for the mammalian transferrin receptor (55). Since
transferrin exists in vivo in a partially saturated state (56), the
ability of Tbp2 to differentiate between ferrated transferrin
and apotransferrin might allow the gonococcus to identify fer-
rated transferrin molecules rapidly and bind them preferen-
tially. The ability of Tbp2 to discriminate between these two
forms of transferrin also could be important in release of
transferrin from the cell surface after the iron has been re-
moved. Blanton et al. (9) reported that the gonococcus, like
the meningococcus (48), could discriminate slightly between
ferrated and apotransferrin in the solid-phase, transferrin-
binding assay but that they were unable to detect differential
binding to the wild-type strain in liquid-phase experiments (9).
In this study, we were able to detect discrimination between
ferrated transferrin and apotransferrin by the wild-type strain
in both liquid-phase and solid-phase experiments in the pres-
ence of deferoxamine mesylate. The extent of binding and
discrimination by Tbp2 was underestimated in the solid-phase
binding experiments.
Tbp1 and Tbp2 appear to interact with one another in wild-
type gonococci, as evidenced by the altered properties exhib-
ited by the separated proteins in the affinity purification assay.
Sarkosyl-solubilized Tbp2 could be affinity purified in the pres-
ence but not in the absence of Tbp1, suggesting that Tbp2
might have bound to transferrin through Tbp1 under these
conditions. Alternatively, Tbp2 in the absence of Tbp1 may
have adopted a different conformation so that it no longer
bound to transferrin in Sarkosyl. We found that Tbp2 without
Tbp1 did not bind to transferrin in Sarkosyl, but binding was
observed in the nonionic detergent Triton X-100. Since both
proteins were capable of binding independently to transferrin
in the affinity purification assay, given the appropriate deter-
gent solubilization conditions, both proteins obviously were
capable of independent transferrin binding and were not si-
multaneously required to reconstitute a binding site. More
Tbp1 was purified as the salt concentration of the Sarkosyl-
containing wash solution was increased, possibly because high-
ionic-strength conditions enhanced hydrophobic interactions
between Tbp1 and transferrin.
Protease accessibility experiments suggested that the confor-
mation or exposure of Tbp2 was dependent upon the presence
of Tbp1, consistent with the hypothesis that the two proteins
interact. When Tbp1 was absent, virtually all of the expressed
Tbp2 was readily accessible to trypsin. When Tbp1 was
present, as in the wild-type strain, a portion of the expressed
Tbp2 remained resistant to trypsin exposure for at least 30 min
while a fraction was trypsin accessible. It is possible that the
apparent effect of Tbp1 on the conformation of Tbp2 was
indirect. The absence of Tbp1 in the membrane may have
altered the conformation and/or protease accessibility of Tbp2.
Membranes lacking Tbp1 might be more prone to lysis or bleb
formation, which may expose Tbp2 abnormally, although Fbp
was not accessible to trypsin in these cultures. The exquisite
sensitivity of Tbp1 to relatively low trypsin concentrations was
in contrast to observations for outer membrane porins (46, 52),
which were found to be relatively protease resistant. Tbp1
expressed without Tbp2 was more susceptible to trypsin than it
was in the wild-type strain. In the presence of both transferrin
and Tbp2, Tbp1 was quite resistant to trypsin exposure. On the
other hand, Tbp2 appeared more susceptible to cleavage by
trypsin when both Tbp1 and transferrin were present. This may
suggest that when both Tbp1 and Tbp2 are present, ligand
binding causes Tbp2 to adopt a more open conformation,
allowing more access by trypsin. The trypsin accessibilities of
both Tbp1 and Tbp2 in whole cells argue strongly that the
proteins interact at the cell surface.
The results presented here suggest a model in which both
Tbp1 and Tbp2 are surface-exposed, transferrin-binding pro-
teins that together constitute the functional transferrin recep-
tor, although both proteins can bind transferrin independently.
Tbp1, by its homology with the TonB-dependent outer mem-
brane receptors, is postulated to form the channel through
which the iron from transferrin traverses the outer membrane
(16). The affinity purification assays and protease accessibility
experiments suggest that Tbp1 and Tbp2 interact, since the
presence of Tbp1 influences the binding properties and con-
formation or exposure of Tbp2. Similarly, Tbp2 effects the
binding and exposure properties of Tbp1. Tbp2, although not
essential for growth on transferrin as an iron source in vitro
(2), may increase the specificity of the functional receptor for
ferrated transferrin and/or may be employed in release of the
deferrated transferrin from the functional receptor once the
iron has been removed.
The protease accessibility experiments suggested that Tbp2
exists in at least two conformations in the wild-type strain. In
one form, Tbp2 is in an open, protease-accessible conforma-
tion, and in another form, Tbp2 is in a more closed conforma-
tion or is less accessible. Perhaps when Tbp2 is expressed
without Tbp1 it exists in essentially one protease-sensitive
form. Tbp2 in this protease-sensitive state is able to distinguish
between ferrated transferrin and apotransferrin. These obser-
vations suggest that some aspect of Tbp1 conformation, func-
tion, or energization might alter the conformation of Tbp2 in
the wild-type strain, thereby interconverting Tbp2 between
protease-sensitive and protease-resistant states. In this model,
the two transferrin-binding sites predicted from the binding
data might be interpreted as two conformational states of the
transferrin receptor, consisting of both Tbp1 and Tbp2. These
binding conformations might then correspond to the open and
closed forms expressed by Tbp2. Support for this speculative
model of transferrin receptor structure and function will re-
quire further experimentation.
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